2상모집 중단 (진행 중)

Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

연구 개요

The purpose of the study is to see if participants with anemia due to their type of MDS or MDS/MPN will experience a more decreased need for regular blood transfusions if they take luspatercept plus best supportive care, and what effect, good and/or bad, luspatercept has on them and their anemia due to MDS or MDS/MPN. The safety and tolerability of luspatercept will also be evaluated in this study.

스폰서
협력: BMS
적응증
Myelodysplastic Syndromes, Myeloproliferative Neoplasm, Anemia
중재
Luspatercept
목표 등록
6
시작일
2023-02-21
완료(예정)
2026-09-01

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.